Vatsala Katiyar is an Oncology physician affiliated with Illinois CancerCare. OpenAlex indexes 79 publications with 267 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8940 N Wood Sage Rd
Peoria, IL 616157822
Telephone
309-243-3000Provider last certified this registry record 2 Mar 2026.
Industry payments
44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
- PFIZER INC.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
55.3%Iron, parenteral preparations43.5%Ferric carboxymaltose100%Part B, office-administered≥15 patientsErythropoiesis-stimulating Agent11.7%Darbepoetin alfa83%Epoetin alfa17%Part B, office-administered≥12 patients+ 1 more class in this area
Cancer & immunology
30.6%PD-1 inhibitor29%Pembrolizumab100%Part B, office-administered≥20 patientsNucleoside Metabolic Inhibitor0.5%Fluorouracil100%Part B, office-administered≥13 patients+ 8 more classes in this area
Musculoskeletal
6.5%RANK Ligand Inhibitor6.5%Denosumab100%Part B, office-administered≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Updates on the Treatment of Tenosynovial Giant Cell Tumor
Hematology/Oncology and Stem Cell Therapy
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gary Macvicar, MD
Illinois CancerCare
Michael Veeder, MD
Illinois CancerCare
Francois Geoffroy, MD
Illinois CancerCare
Paul Fishkin, MD
Illinois CancerCare
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”